A phase I study to evaluate the safety and toxicity of the combination of zidovudine and 2',3'-dideoxyinosine (didanosine) in children with HIV infection
Phase of Trial: Phase I
Latest Information Update: 14 Mar 2014
At a glance
- Drugs Didanosine (Primary) ; Zidovudine (Primary)
- Indications HIV infections
- Focus Adverse reactions
- 11 Oct 2005 New trial record.